相关实验视频
Updated: Jul 28, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.7K
放射治疗与免疫治疗相结合,成功治疗了一例形甲状腺癌:一个病例报告
Yurou Xing1, Yongsheng Wang1, Xin Wu2
1Thoracic Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in oncology
|May 31, 2023
概括
无塑性甲状腺癌 (ATC) 是一种罕见的,激进的癌症. 将tislelizumab免疫疗法与放射疗法结合起来,有望缩小瘤并改善晚期病例的结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 辐射瘤学 辐射瘤学
背景情况:
- 无塑性甲状腺癌 (ATC) 是一种罕见且具有不良预后的侵袭性恶性瘤.
- 尽管最近的治疗进展,但由于迅速进展,转移和复发,ATC的结果仍然不令人满意.
相关概念视频
Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K

